These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17243936)

  • 1. Recent progress on the topical therapy of onychomycosis.
    Alley MR; Baker SJ; Beutner KR; Plattner J
    Expert Opin Investig Drugs; 2007 Feb; 16(2):157-67. PubMed ID: 17243936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tavaborole - a treatment for onychomycosis of the toenails.
    Gupta AK; Versteeg SG
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1145-52. PubMed ID: 27347905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapeutic agents for onychomycosis.
    Piérard GE; Arrese JE; Quatresooz P; Piérard-Franchimont C
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):345-53. PubMed ID: 17874965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tavaborole 5% Solution: A Novel Topical Treatment for Toenail Onychomycosis.
    Gupta G; Foley KA; Gupta AK
    Skin Therapy Lett; 2015 Nov; 20(6):6-9. PubMed ID: 27224843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.
    Adigun CG; Vlahovic TC; McClellan MB; Thakker KD; Klein RR; Elstrom TA; Ward DB
    J Drugs Dermatol; 2016 Sep; 15(9):1116-20. PubMed ID: 27602975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis: burden of disease and the role of topical antifungal treatment.
    Daniel RC
    J Drugs Dermatol; 2013 Nov; 12(11):1263-6. PubMed ID: 24196334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults.
    Gupta AK; Daigle D
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):735-42. PubMed ID: 24894552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efinaconazole and Tavaborole.
    Poulakos M; Grace Y; Machin JD; Dorval E
    J Pharm Pract; 2017 Apr; 30(2):245-255. PubMed ID: 26873506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on tavaborole for the treatment of onychomycosis.
    Jinna S; Finch J
    Drug Des Devel Ther; 2015; 9():6185-90. PubMed ID: 26640371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging topical onychomycosis therapies - quo vadis?
    Elkeeb R; Hui X; Murthy N; Maibach HI
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.
    De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D
    Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tavaborole 5% Topical Solution for the Treatment of Toenail Onychomycosis in Pediatric Patients: Results from a Phase 4 Open-Label Study.
    Rich P; Spellman M; Purohit V; Zang C; Crook TJ
    J Drugs Dermatol; 2019 Feb; 18(2):190-195. PubMed ID: 30811142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of tavaborole for the treatment of onychomycosis.
    Gupta AK; Daigle D
    Future Microbiol; 2014; 9(11):1243-50. PubMed ID: 25437186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tavaborole topical solution (Kerydin) for onychomycosis.
    Med Lett Drugs Ther; 2015 Mar; 57(1463):35-6. PubMed ID: 25719999
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
    Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R
    J Am Acad Dermatol; 2015 Jul; 73(1):62-9. PubMed ID: 25956661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate.
    Hui X; Baker SJ; Wester RC; Barbadillo S; Cashmore AK; Sanders V; Hold KM; Akama T; Zhang YK; Plattner JJ; Maibach HI
    J Pharm Sci; 2007 Oct; 96(10):2622-31. PubMed ID: 17621679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.
    Zane LT; Plattner J; Chanda S; Coronado D; Merchant T; Alley MR; Gupta AK
    Drugs Today (Barc); 2015 Oct; 51(10):599-607. PubMed ID: 26583302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Tavaborole in the Treatment of Onychomycosis Complicated by Dermatophytoma: A Post-hoc Assessment of Phase II Subjects.
    Aly R; Winter T; Hall S; Vlahovic T
    J Drugs Dermatol; 2018 Mar; 17(3):347-354. PubMed ID: 29537453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antifungal therapies for the treatment of onychomycosis.
    Kumar S; Kimball AB
    Expert Opin Investig Drugs; 2009 Jun; 18(6):727-34. PubMed ID: 19426118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tavaborole in Difficult-to-Treat Onychomycosis Cases: A Post-hoc Assessment of Phase III Subjects.
    Aly R; Gupta AK; Winter T; Zane LT; Vlahovic T
    J Drugs Dermatol; 2017 Oct; 16(10):1016-1021. PubMed ID: 29036255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.